MOTS-c
MOTS-c. Mitochondrial-derived peptide for metabolic regulation.
How it works. Activates AMPK and folate-methionine cycle.
What the research supports. 1 graded claims. Strongest: Improves insulin sensitivity (moderate).
How much to take. Typical dose: Research only.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with NAD+ precursor (NMN or NR), Omega-3.
Common forms. Available as Subcutaneous injection, Oral or sublingual lozenge, Nasal spray, Compounded topical.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried MOTS-c. Anecdotes are not medical advice.
MOTS-c. Mitochondrial-derived peptide for metabolic regulation.
What it is
Mitochondrial-derived peptide for metabolic regulation.
Food sources
Goals
How it works
Activates AMPK and folate-methionine cycle.
Pathways
- Activates AMPK
- folate-methionine cycle
Effects
- +insulin sensitivity supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Insufficient human data
Medication interactions
Always disclose MOTS-c use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- NAD+ precursor (NMN or NR)Complementary mitochondrial and sirtuin support.
- Omega-3Lowers inflammation and supports membrane integrity.
Common forms
- Subcutaneous injection
- Oral or sublingual lozenge
- Nasal spray
- Compounded topical
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching MOTS-c and "Improves insulin sensitivity". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching MOTS-c and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching MOTS-c and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…